Un-personalized medicine: the challenges of vaccines as a single medicine for a whole population

The simple message is that vaccines have had an enormous beneficial impact of in reducing infection, disease and death.But vaccines themselves are not simple, the last 5 years have (re)taught us how incredibly complex they are.A critical consideration is that vaccines are both an individual drug and a population level intervention.At the individual level, consumers want a risk-free product with minimal side effects.The ideal vaccine would provide lifelong, sterilising immunity, preventing infection from ever taking hold in the first place, or if infection occurs rapidly clearing the pathogen with no symptoms.However, from a public health perspective, different outcomes and endpoints might be more of a

Authors

Institutions

Publication Details

Journal
Clinical & Experimental Immunology
Published
2025-01-01
DOI
https://doi.org/10.1093/cei/uxaf062
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Un-personalized medicine: the challenges of vaccines as a single medicine for a whole population

John S. Tregoning, Vanessa Sancho‐Shimizu
Clinical & Experimental Immunology
Biotechnology and Related Fields
article

Un-personalized medicine: the challenges of vaccines as a single medicine for a whole population

John S. Tregoning, Vanessa Sancho‐Shimizu
article en

Abstract

The simple message is that vaccines have had an enormous beneficial impact of in reducing infection, disease and death.But vaccines themselves are not simple, the last 5 years have (re)taught us how incredibly complex they are.A critical consideration is that vaccines are both an individual drug and a population level intervention.At the individual level, consumers want a risk-free product with minimal side effects.The ideal vaccine would provide lifelong, sterilising immunity, preventing infection from ever taking hold in the first place, or if infection occurs rapidly clearing the pathogen with no symptoms.However, from a public health perspective, different outcomes and endpoints might be more of a

Clinical & Experimental ImmunologyVol. 219(1)
Imperial College London (GB)
Openalex Percentile: Top 66%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.